Jubilant Pharmova Ltd.

472.60 -2.00 ▼-0.4%

08 December 2023, 04:05:38 PM
Volume: 679,827

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.jubilantpharmova.com
Market Cap 7,535.59 Cr.
Enterprise Value(EV) 9,921.56 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -2.80 Trailing Twelve Months Ending 2023-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-09
Industry PE 38.54 Trailing Twelve Months Ending 2023-09
Book Value / Share 339.67 Trailing Twelve Months Ending 2023-09
Price to Book Value 1.39 Calculated using Price: 473.10
Dividend Yield 1.06 Period Ending 2023-03
No. of Shares Subscribed 15.93 Cr. 159,281,139 Shares
FaceValue 1
About Jubilant Pharmova Ltd.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals. Jubilant Pharma Limited, is engaged in manufacturing and supply of APIs, solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six USFDA approved manufacturing facilities in the US, Canada and India and a network of various radiopharmacies in the US.

Jubilant Pharmova Ltd. Delivery

Delivered Qty
Traded Qty

Jubilant Pharmova Ltd. Performance

1 Day
-0.42%
1 Week
+10.05%
1 Month
+18.88%
3 Month
+1.89%
6 Month
+33.96%
1 Year
+24.37%
2 Year
-20.02%
5 Year
-40.31%
10 Year
+304.62%

Jubilant Pharmova Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -1.58 14.27 17.95 16.87 12.97 13.02 11.09 8.21 -1.21
Return on Capital Employed (%) 5.72 12.42 14.44 15.21 13.06 12.20 12.02 9.97 2.53
Return on Assets (%) -0.46 4.46 6.52 6.91 5.55 5.74 5.45 4.44 -0.63

Jubilant Pharmova Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,454 2,966 3,436 4,087 4,809 5,604 4,741 5,319 5,399 5,410
Non Curr. Liab. 4,036 3,347 3,826 3,417 4,420 4,088 2,973 2,922 3,765 3,974
Curr. Liab. 2,129 2,464 1,684 2,005 2,090 2,619 1,049 1,592 1,772 1,790
Minority Int. -38 -47 -52 0 0 -2 -7 -9
Equity & Liab. 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929 11,166
Non Curr. Assets 5,904 5,864 5,951 6,267 6,734 7,272 5,811 6,320 7,167 7,559
Curr. Assets 2,715 2,875 2,948 3,190 4,585 5,038 2,953 3,509 3,762 3,606
Misc. Exp. not W/O
Total Assets 8,619 8,740 8,899 9,457 11,319 12,310 8,763 9,830 10,929 11,166

Jubilant Pharmova Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09 Rs. Cr. TTM
Net Sales 5,826 5,749 5,861 7,518 9,111 5,976 6,099 6,130 6,282 6,498
Other Income 42 13 25 40 36 37 18 11 38 32
Total Income 5,869 5,763 5,886 7,558 9,147 6,013 6,116 6,141 6,320 6,530
Total Expenditure -5,125 -4,502 -4,516 -5,999 -7,372 -4,428 -4,702 -4,974 -5,505 -5,721
PBIDT 744 1,260 1,370 1,558 1,775 1,585 1,414 1,168 815 809
Interest -368 -371 -341 -284 -220 -200 -184 -145 -188 -234
Depreciation -288 -347 -291 -415 -371 -340 -349 -382 -554 -552
Taxation -80 -155 -163 -225 -327 -335 -297 -217 -93 -94
Exceptional Items -48 -280 -33 -21 -57
PAT -40 387 575 634 577 678 574 413 -65 -71
Minority Interest -18 5 1 8 -3 0 1 4 4
Share Associate 23
Other Related Items
Consolidated Net Profit -58 392 576 643 574 898 836 414 -61 -45
Adjusted EPS -4 25 37 41 36 56 53 26 -4 -3

Jubilant Pharmova Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 772 783 1,099 1,268 1,303 1,122 1,543 1,784 838 661
Cash Fr. Inv. -174 -343 -313 -450 -618 -1,012 -327 -739 -380 -544
Cash Fr. Finan. -414 -503 -843 -686 -901 657 -1,050 -1,709 -33 -157
Net Change 183 -63 -56 132 -216 767 166 -664 425 -40
Cash & Cash Eqvt 473 392 339 456 244 1,005 1,231 502 984 1,014

Jubilant Pharmova Ltd. Shareholding Pattern

9 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%)
Promoter 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68 50.68
Public 49.33 49.32 49.32 49.32 49.32 49.32 49.32 49.32 49.32
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Jubilant Pharmova Ltd. Announcements

Fri, 08 Dec 2023
Updates
Jubilant Pharmova Limited has informed the Exchange regarding 'Financial Results for qtr and half year ended September 30, 2023 in Machine Readable Format'.
Fri, 01 Dec 2023
Loss of Share Certificates
Jubilant Pharmova Limited has informed the Exchange about Loss of Share Certificates
Fri, 17 Nov 2023
Loss of Share Certificates
Jubilant Pharmova Limited has informed the Exchange about Loss of Share Certificates

Jubilant Pharmova Ltd. Technical Scans

Fri, 08 Dec 2023
Higher Trade Quantity Higher Trade Quantity
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Week High Close Above Last Week High
Close Above Last Month High Close Above Last Month High
Making Higher Highs for 2 Days Making Higher Highs for 2 Days

Jubilant Pharmova Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 296,437.84 1,235.50 -0.3%
Cipla Ltd. 98,403.90 1,218.85 -0.3%
Divi's Laboratories Ltd. 97,728.28 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. 96,135.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. 79,685.46 5,542.00 +1.5%
Mankind Pharma Ltd. 78,250.95 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. 69,584.38 2,056.00 -2.2%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 34.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 28.50 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 73.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 18.88 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 114.25 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 61.04 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 52.16 2,056.00 -2.2%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-09 4.96 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-09 3.96 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-09 7.71 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-09 3.77 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-09 12.26 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 9.28 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-09 10.37 2,056.00 -2.2%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,056.00 -2.2%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,056.00 -2.2%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,235.50 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,218.85 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,681.35 -1.4%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,763.50 -0.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,542.00 +1.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,953.40 -2.2%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,056.00 -2.2%

Jubilant Pharmova Ltd. FAQ's

What is Jubilant Pharmova share price?

Can I buy Jubilant Pharmova shares now?

What is the Dividend Yield of Jubilant Pharmova?

What is the Market Cap of Jubilant Pharmova?

What are the key metrics to analyse Jubilant Pharmova?

What is the 52 Week High and Low of Jubilant Pharmova?

What is the trend of Jubilant Pharmova share price?